The study, from the Tisch MS Research Center of New York, is the first to link stem cells with a broad array of improvements in multiple areas Progressive MS patients demonstrated better outcomes in walking speeds, gray matter volume, bladder function, and biomarker indicators NEW YORK–(BUSINESS WIRE)–The Tisch MS Research Center of New York, the … [Read more…]
LAKEWOOD RANCH, Fla.–(BUSINESS WIRE)–DunhamTrimmer, the market leader in business intelligence for the biocontrol, biostimulant, biofertilizer, and specialty nutrition industries, announced today that Ashish Malik will be partnering with the company as Senior Industry Associate. A well-known leader in the biologicals market, Malik brings more than 20 years of experience in senior executive roles with agricultural … [Read more…]
Non-Dilutive and Strengthens Balance Sheet Competitive Process Results in the Sale of 54.5% of the MAVYRET®/MAVIRET® Royalty Interest, Subject to a 1.42x Cap Sale Proceeds to Fund Continuing Clinical Development Across Virology Pipeline WATERTOWN, Mass.–(BUSINESS WIRE)–Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections, today announced … [Read more…]
BOSTON–(BUSINESS WIRE)–Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that management will present at the Bank of America Securities 2023 Health Care Conference on Tuesday, May 9, 2023 at 9:20 a.m. PT/12:20 p.m. ET. A live webcast of management’s remarks will be available through the Vertex website, www.vrtx.com in the “Investors” section under the “News and … [Read more…]
– Fireside Chat May 2, 2023 from 10:00 – 10:30 AM ET – PRINCETON, N.J.–(BUSINESS WIRE)–UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will participate in a fireside chat at the upcoming H.C. Wainwright BioConnect Conference on May … [Read more…]
WATERTOWN, Mass.–(BUSINESS WIRE)–Corner Therapeutics, a biotechnology company exploiting a new scientific paradigm to boost the intelligence of the natural immune response to disease, today announced the appointment of Rick Malley, M.D., to their Scientific Advisory Board. Malley is experienced in pediatric infectious disease, with his prior work focused on developing novel vaccine platforms and pneumococcal … [Read more…]
CAMBRIDGE, Mass.–(BUSINESS WIRE)–VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that Vaughn B. Himes, Ph.D., Chief Technical Officer of Seagen Inc., has joined VBI’s Board of Directors. Dr. Himes has a 30+-year successful track record in biotechnology strategic direction … [Read more…]
Newly Released Report Details Company’s Progress and Plans for Growing Responsibly BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass.–(BUSINESS WIRE)–$BGNE #BTKi–BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, announced several new Environmental, Social, and Governance (ESG) goals today, including targets related to carbon emissions and workforce diversity. These goals are outlined in the … [Read more…]
Funding is amplified by recognition as first Amgen Golden Ticket winner in Singapore SINGAPORE–(BUSINESS WIRE)–Albatroz Therapeutics, a biotechnology company targeting tissue remodeling to stop cancer growth and treat arthritis, today announced it has secured $3 million USD in funding led by Outram Bio and SEEDS Capital to accelerate the development of therapeutic antibodies against a … [Read more…]
TORONTO–(BUSINESS WIRE)–$ATBPF–Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical-stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapies to target inflammation, today announced its participation in the Precision in Clinical Trials Summit being held in Boston on May 1 – 2, 2023. Dr. Joseph Stauffer, Antibe’s Chief Medical Officer, will deliver a … [Read more…]
